Last Seven Days

27 articles from the last seven days

• 
  Medicine moves to OTC to ease access issues

  A previously prescription-only drug has hit the shelves as a pharmacy drug, with the hope it will increase awareness of the ability to treat symptoms

  7 Sep 2026
• 
  Redundancies hit pharma spin-off

  Jobs have been cut following a recent field force review with changes made to ensure the company's customer coverage model reflects an evolving market

  7 Sep 2026
• 
  Company takes second tilt at a PBAC 'Yes'

  The agenda for the November PBAC meeting has been updated with one company rejected in July making quick work of trying again

  7 Sep 2026
• 
  TGA approval lands in the nick of time

  A new asthma treatment set to be considered for PBS funding at the PBAC's intracycle meeting this month has been approved for use in Australia

  7 Sep 2026
• 
  Pharma promotes exec to Country Lead

  High-flyer has been promoted to Country Lead, taking responsibility for heading the company's innovative medicines business in Australia

  7 Sep 2026
• 
  Familiar faces pick up Eureka Prizes

  From banning discrimination in genetic testing to ground-breaking infectious disease discoveries, this year's Eureka prizes saw well-known names take home gongs

  4 Sep 2026
• 
  Who's cracked America’s Best Companies list?

  Despite the overall trend of tech dominance in the US, two pharmaceutical companies have broken into TIME’s Top 10 list of America’s Best Companies for 2026.

  4 Sep 2026
• 
  Double or nothing: Unlocking access to new drugs

  Medicines Australia has outlined an ambitious plan for the Government to double its spending on innovative medicines

  4 Sep 2026
• 
  Pharma bosses call out work-life balance

  Two senior pharma executives - one a former Aussie GM - have called out perfect work-life balance as an unrealistic expectation placed on the industry

  4 Sep 2026
• 
  This drug won a standing ovation but will Aussies ever see it?

  A breakthrough drug for pancreatic cancer was given a standing ovation at ASCO this year but for Australian patients there's likely a long wait ahead

  4 Sep 2026
• 
  ACCC approves $68 billion acquisition

  The ACCC has given the go-ahead for the merger of a Johnson & Johnson spin-out with another mega company... but on one condition

  3 Sep 2026
• 
  Sydney exec lands GM role overseas

  Stepping up from a Business Unit Director role, this executive has packed her bags and made the move to Bulgaria, to take on the position of General Manager at a Big Pharma

  3 Sep 2026
• 
  BMS notches a first with TGA tick

  Once-daily pill, the first treatment of its kind to be registered in Australia for a debilitating condition, marks an 'important milestone' for patients

  3 Sep 2026
• 
  Another domino falls for drug in TGA probe

  With another jurisdiction revoking approval, it's not looking good for a drug that has been linked to eight deaths overseas that is being reviewed by the TGA.

  3 Sep 2026
• 
  Does Aussie pharma pass the Pub Test?

  Companies have been urged to apply the "PUB Test" to upcoming initiatives designed to engage HCPs - before they go to market - otherwise they risk missing the mark

  3 Sep 2026
• 
  What's the Govt's ROI on mRNA initiatives?

  Millions of dollars have been spent by the Victorian Government to nurture the mRNA industry in the state, and a new Impact Report details whether it's delivered

  2 Sep 2026
• 
  Pharma rejoins Medicines Australia

  Several years after leaving the industry body, this company has returned as a Class 1 member, saying the innovative medicines sector is strongest when it works together

  2 Sep 2026
• 
  Big Pharma picks Sydney CBD for new HQ

  General Manager announces a “fresh start” for the pharma in a slick new office space with the latest technology and design to enable flexible-based working plus connection with patients and partners

  2 Sep 2026
• 
  Who’s up for a 2026 PRIME Award?

  The 22nd PRIME Awards have attracted entries from more organisations than ever before making this one of the strongest and most competitive fields in the event's history

  2 Sep 2026
• 
  The secrecy that hampers PBAC decisions

  There can be clear disagreements over the price which should be paid for a drug, but some features of the reimbursement system mean neither side really knows what the other expects

  2 Sep 2026